Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays

A. R. De Roodt, H. Clement, J. A. Dolab, S. Litwin, S. E. Hajos, Leslie V Boyer, A. Alagón

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Context. Therapy for snakebites relies on the application of antivenoms, which may be produced with different immunogenic mixtures of venom and possess different pharmaceutical characteristics. For these reasons, immunological cross-reactivity and heterologous neutralization were analyzed relative to the protein content of three antivenoms used in the Americas. Methods. The antivenoms studied were composed of equine F(ab')2 fragments from animals immunized with Crotalinae venoms. The antivenoms were tested against venoms of seven pit viper species from Argentina, seven from Mexico, one from Costa Rica, and one from Colombia. Results. Immunoblotting showed high cross-reactivity of all major protein bands with all the antivenoms tested. ELISA results also showed high cross-reactivity among the different venoms and antivenoms, and a high heterologous neutralization was observed. The results can be interpreted in different ways depending on whether the reactivity is considered in terms of the volume of antivenom used or by the amount of protein contained in this volume of antivenom. The antivenoms with high immunochemical reactivity and neutralizing capacity were those with higher protein content per vial; but when doses were adjusted by protein content, antivenoms of apparently lower neutralizing capacity and immunochemical reactivity showed at least similar potency and reactivity although volumetrically at higher doses. Conclusion. Protein content relative to neutralization potency of different products must be taken into account when antivenoms are compared, in addition to the volume required for therapeutic effect. These results show the importance of obtaining high-affinity and high-avidity antibodies to achieve good neutralization using low protein concentration and low-volume antivenoms.

Original languageEnglish (US)
Pages (from-to)594-603
Number of pages10
JournalClinical Toxicology
Volume52
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Antivenins
Assays
Proteins
Venoms
Crotalid Venoms
Snake Bites
Costa Rica
Antibody Affinity
Colombia
Argentina
Therapeutic Uses
Mexico
Immunoblotting
Horses
Animals

Keywords

  • Antivenins
  • Snakes
  • Toxinology

ASJC Scopus subject areas

  • Toxicology

Cite this

Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays. / De Roodt, A. R.; Clement, H.; Dolab, J. A.; Litwin, S.; Hajos, S. E.; Boyer, Leslie V; Alagón, A.

In: Clinical Toxicology, Vol. 52, No. 6, 2014, p. 594-603.

Research output: Contribution to journalArticle

De Roodt, A. R. ; Clement, H. ; Dolab, J. A. ; Litwin, S. ; Hajos, S. E. ; Boyer, Leslie V ; Alagón, A. / Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays. In: Clinical Toxicology. 2014 ; Vol. 52, No. 6. pp. 594-603.
@article{be6b240517234e8ea82dc7504f7207f0,
title = "Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays",
abstract = "Context. Therapy for snakebites relies on the application of antivenoms, which may be produced with different immunogenic mixtures of venom and possess different pharmaceutical characteristics. For these reasons, immunological cross-reactivity and heterologous neutralization were analyzed relative to the protein content of three antivenoms used in the Americas. Methods. The antivenoms studied were composed of equine F(ab')2 fragments from animals immunized with Crotalinae venoms. The antivenoms were tested against venoms of seven pit viper species from Argentina, seven from Mexico, one from Costa Rica, and one from Colombia. Results. Immunoblotting showed high cross-reactivity of all major protein bands with all the antivenoms tested. ELISA results also showed high cross-reactivity among the different venoms and antivenoms, and a high heterologous neutralization was observed. The results can be interpreted in different ways depending on whether the reactivity is considered in terms of the volume of antivenom used or by the amount of protein contained in this volume of antivenom. The antivenoms with high immunochemical reactivity and neutralizing capacity were those with higher protein content per vial; but when doses were adjusted by protein content, antivenoms of apparently lower neutralizing capacity and immunochemical reactivity showed at least similar potency and reactivity although volumetrically at higher doses. Conclusion. Protein content relative to neutralization potency of different products must be taken into account when antivenoms are compared, in addition to the volume required for therapeutic effect. These results show the importance of obtaining high-affinity and high-avidity antibodies to achieve good neutralization using low protein concentration and low-volume antivenoms.",
keywords = "Antivenins, Snakes, Toxinology",
author = "{De Roodt}, {A. R.} and H. Clement and Dolab, {J. A.} and S. Litwin and Hajos, {S. E.} and Boyer, {Leslie V} and A. Alag{\'o}n",
year = "2014",
doi = "10.3109/15563650.2014.925561",
language = "English (US)",
volume = "52",
pages = "594--603",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays

AU - De Roodt, A. R.

AU - Clement, H.

AU - Dolab, J. A.

AU - Litwin, S.

AU - Hajos, S. E.

AU - Boyer, Leslie V

AU - Alagón, A.

PY - 2014

Y1 - 2014

N2 - Context. Therapy for snakebites relies on the application of antivenoms, which may be produced with different immunogenic mixtures of venom and possess different pharmaceutical characteristics. For these reasons, immunological cross-reactivity and heterologous neutralization were analyzed relative to the protein content of three antivenoms used in the Americas. Methods. The antivenoms studied were composed of equine F(ab')2 fragments from animals immunized with Crotalinae venoms. The antivenoms were tested against venoms of seven pit viper species from Argentina, seven from Mexico, one from Costa Rica, and one from Colombia. Results. Immunoblotting showed high cross-reactivity of all major protein bands with all the antivenoms tested. ELISA results also showed high cross-reactivity among the different venoms and antivenoms, and a high heterologous neutralization was observed. The results can be interpreted in different ways depending on whether the reactivity is considered in terms of the volume of antivenom used or by the amount of protein contained in this volume of antivenom. The antivenoms with high immunochemical reactivity and neutralizing capacity were those with higher protein content per vial; but when doses were adjusted by protein content, antivenoms of apparently lower neutralizing capacity and immunochemical reactivity showed at least similar potency and reactivity although volumetrically at higher doses. Conclusion. Protein content relative to neutralization potency of different products must be taken into account when antivenoms are compared, in addition to the volume required for therapeutic effect. These results show the importance of obtaining high-affinity and high-avidity antibodies to achieve good neutralization using low protein concentration and low-volume antivenoms.

AB - Context. Therapy for snakebites relies on the application of antivenoms, which may be produced with different immunogenic mixtures of venom and possess different pharmaceutical characteristics. For these reasons, immunological cross-reactivity and heterologous neutralization were analyzed relative to the protein content of three antivenoms used in the Americas. Methods. The antivenoms studied were composed of equine F(ab')2 fragments from animals immunized with Crotalinae venoms. The antivenoms were tested against venoms of seven pit viper species from Argentina, seven from Mexico, one from Costa Rica, and one from Colombia. Results. Immunoblotting showed high cross-reactivity of all major protein bands with all the antivenoms tested. ELISA results also showed high cross-reactivity among the different venoms and antivenoms, and a high heterologous neutralization was observed. The results can be interpreted in different ways depending on whether the reactivity is considered in terms of the volume of antivenom used or by the amount of protein contained in this volume of antivenom. The antivenoms with high immunochemical reactivity and neutralizing capacity were those with higher protein content per vial; but when doses were adjusted by protein content, antivenoms of apparently lower neutralizing capacity and immunochemical reactivity showed at least similar potency and reactivity although volumetrically at higher doses. Conclusion. Protein content relative to neutralization potency of different products must be taken into account when antivenoms are compared, in addition to the volume required for therapeutic effect. These results show the importance of obtaining high-affinity and high-avidity antibodies to achieve good neutralization using low protein concentration and low-volume antivenoms.

KW - Antivenins

KW - Snakes

KW - Toxinology

UR - http://www.scopus.com/inward/record.url?scp=84903156648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903156648&partnerID=8YFLogxK

U2 - 10.3109/15563650.2014.925561

DO - 10.3109/15563650.2014.925561

M3 - Article

C2 - 24940642

AN - SCOPUS:84903156648

VL - 52

SP - 594

EP - 603

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 6

ER -